$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
白血病第三代药物普纳替尼图片及介绍
2025-10-19 11:44:20
Check Details
维奈托克(唯可来)对慢性淋巴细胞白血病的作用
2025-10-19 11:44:20
Check Details
普纳替尼什么时候中国内地上市?
2025-10-19 11:44:20
Check Details
普纳替尼治疗慢性粒性白血病的疗效显著
2025-10-19 11:44:20
Check Details
白血病三代药普纳替尼多少钱一盒?
2025-10-19 11:44:20
Check Details
普纳替尼获批用于两类罕见白血病的治疗
2025-10-19 11:44:20
Check Details
尼洛替尼一线治疗慢性髓性白血病的效果
2025-10-19 11:44:20
Check Details
普纳替尼治疗罕见白血病的效果怎么样?
2025-10-19 11:44:20
Check Details
尼洛替尼用于慢性髓性白血病慢性期的安全性及有效性
2025-10-19 11:44:20
Check Details
白血病的克星维奈托克一盒多少钱?
2025-10-19 11:44:20
Check Details
慢性粒性白血病吃普纳替尼最长吃几年?
2025-10-19 11:44:20
Check Details
FDA批准普纳替尼用于治疗慢性髓性白血病
2025-10-19 11:44:20
Check Details
1
2
...
597
598
599
600
601
602
603
...
938
939
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Belumosudil for cGVHD: 200mg with Food, Pregnancy Contraception, Liver Monitoring, Drug Interactions
2
Acalabrutinib in CLL/SLL Survival Expectation: ELEVATE-TN and ASCEND Long-Term PFS, OS
3
Bosutinib for CML: Time to Response, BCR-ABL Monitoring, and Molecular Remission
4
Acalabrutinib Dosing and Combination Regimens: CLL/SLL, MCL, Safety Adjustments
5
Bosutinib for Ph+ CML: Indications, Dosing Adjustments, and Hepatic/Renal Safety
6
AZA+VEN+IVO Triplet Therapy for Newly Diagnosed IDH1 AML: High Response Rates and Durable Efficacy
7
Anagrelide and Myelofibrosis Risk: Controversy and Monitoring in ET Treatment
8
Acalabrutinib Dosing Guide: Dosage, Duration and Precautions
9
Enasidenib: A Targeted IDH2 Inhibitor for Acute Myeloid Leukemia
10
Ponatinib in Chronic Myeloid Leukemia: 5-Year Results from the OPTIC Trial
11
Midostaurin (Rydapt): Dosing Essentials in FLT3-Mutated AML and Systemic Mastocytosis
12
Bosutinib Indications Explained: CML Targeted Therapy and ADPKD Research Insights